Literature DB >> 27569069

Vasculogenic mimicry and tumor metastasis.

Jingxin Zhang1, Lili Qiao, Ning Liang, Jian Xie, Hui Luo, Guodong Deng, Jiandong Zhang.   

Abstract

Vasculogenic mimicry (VM), a microvascular channel made up of nonendothelial cells, has been accepted as a new model of neovascularization in aggressive tumors, owning to the specific capacity of malignant cells to form vessel-like networks which provide sufficient blood supply for tumor growth. Multiple molecular mechanisms, especially vascular endothelial (VE)-cadherin, erythropoietin-producing hepatocellular receptor A2 (EphA2), phosphatidyl inositol 3-kinase (PI3K), matrix metalloproteinases (MMPs), vascular endothelial growth factor receptor (VEGFR1), and hypoxia inducible factor (HIF)-1a, have been reported to participate in VM formation which is associated with tumor migration and invasion. In addition, hypoxia, cancer stem cells (CSCs) and epithelial-mesenehymal transition (EMT) are regarded as significant factors in VM formation and tumor metastasis. Due to the important effects of VM on tumor progression, a review was carried out in the present study, to synthetically analyze the relationship between VM and tumor metastasis.

Entities:  

Mesh:

Year:  2016        PMID: 27569069

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  23 in total

1.  Orchestrated expression of vasculogenic mimicry and laminin-5γ2 is an independent prognostic marker in oral squamous cell carcinoma.

Authors:  Depanwita Saha; Debarpan Mitra; Neyaz Alam; Sagar Sen; Saunak Mitra Mustafi; Syamsundar Mandal; Biswanath Majumder; Nabendu Murmu
Journal:  Int J Exp Pathol       Date:  2022-02-16       Impact factor: 1.925

Review 2.  The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Metastasis Rev       Date:  2021-10-18       Impact factor: 9.264

3.  Expression of vimentin and Oct-4 in gallbladder adenocarcinoma and their relationship with vasculogenic mimicry and their clinical significance.

Authors:  Yu Zhang; Jing Xu; Zhouyi Xu; Yichao Wang; Shiwu Wu; Lu Wu; Hong Song; Lei Zhou
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

4.  CORR® Tumor Board: Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?

Authors:  Megan E Anderson; Jim S Wu; Sara O Vargas
Journal:  Clin Orthop Relat Res       Date:  2020-06       Impact factor: 4.755

5.  Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy.

Authors:  Zhe Zhao; Shufen Xiang; Jindan Qi; Yijun Wei; Mengli Zhang; Jun Yao; Tong Zhang; Mei Meng; Xiaohua Wang; Quansheng Zhou
Journal:  Cell Death Dis       Date:  2020-05-21       Impact factor: 8.469

6.  TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer.

Authors:  Yi Wang; Huizhi Sun; Danfang Zhang; Dan Fan; Yanhui Zhang; Xueyi Dong; Shiqi Liu; Zhao Yang; Chunsheng Ni; Yanlei Li; Fang Liu; Xiulan Zhao
Journal:  J Cell Mol Med       Date:  2018-04-14       Impact factor: 5.310

Review 7.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

8.  Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer.

Authors:  Ming Gu; Xinyu Zheng
Journal:  Onco Targets Ther       Date:  2017-08-18       Impact factor: 4.147

9.  LRIG1 acts as a critical regulator of melanoma cell invasion, migration, and vasculogenic mimicry upon hypoxia by regulating EGFR/ERK-triggered epithelial-mesenchymal transition.

Authors:  Wei Li; Yubo Zhou
Journal:  Biosci Rep       Date:  2019-01-08       Impact factor: 3.840

10.  Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer.

Authors:  Qunwei Chen; Wanfu Lin; Zifei Yin; Yong Zou; Shufang Liang; Shanming Ruan; Peifeng Chen; Shu Li; Qijin Shu; Binbin Cheng; Changquan Ling
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.